Published in J Clin Microbiol on January 11, 2012
Characterization of Streptococcus tigurinus small-colony variants causing prosthetic joint infection by comparative whole-genome analyses. J Clin Microbiol (2013) 0.96
Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections. Clin Microbiol Rev (2016) 0.89
The novel species Streptococcus tigurinus and its association with oral infection. Virulence (2014) 0.83
Evolution of Staphylococcus aureus under vancomycin selective pressure: the role of the small-colony variant phenotype. Antimicrob Agents Chemother (2014) 0.82
Optimized In Vitro Antibiotic Susceptibility Testing Method for Small-Colony Variant Staphylococcus aureus. Antimicrob Agents Chemother (2016) 0.79
Phenotypic and Genotypic Characteristics of Small Colony Variants and Their Role in Chronic Infection. Microbiol Insights (2015) 0.77
Reduced Innate Immune Response to a Staphylococcus aureus Small Colony Variant Compared to Its Wild-Type Parent Strain. Front Cell Infect Microbiol (2016) 0.75
Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis (1998) 3.61
Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis (1994) 2.91
Comparison of direct colony method versus extraction method for identification of gram-positive cocci by use of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2011) 2.67
Esp-independent biofilm formation by Enterococcus faecalis. J Bacteriol (2004) 2.20
Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J (2004) 1.90
Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. J Bacteriol (2006) 1.81
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol (1987) 1.80
Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb Drug Resist (2002) 1.69
Simultaneous detection of Staphylococcus aureus and coagulase-negative staphylococci in positive blood cultures by real-time PCR with two fluorescence resonance energy transfer probe sets. J Clin Microbiol (2004) 1.63
Comparison of susceptibility testing methods with mecA gene analysis for determining oxacillin (methicillin) resistance in clinical isolates of Staphylococcus aureus and coagulase-negative Staphylococcus spp. J Clin Microbiol (1999) 1.59
Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol (2010) 1.48
Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr Biol (2001) 1.48
Regulation of slime production in Staphylococcus epidermidis by iron limitation. Infect Immun (1993) 1.45
Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J Med Microbiol (2009) 1.43
Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis (2010) 1.43
Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney. J Infect Dis (2003) 1.39
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob Agents Chemother (2006) 1.37
Staphylococcus aureus small colony variants, electron transport and persistent infections. Int J Antimicrob Agents (2000) 1.31
Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus. Int J Med Microbiol (2007) 1.29
In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus. J Bacteriol (2007) 1.27
The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother (2008) 1.26
Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation (1997) 0.97
Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus. Infect Immun (2007) 0.97
Enhanced production of exopolysaccharide matrix and biofilm by a menadione-auxotrophic Staphylococcus aureus small-colony variant. J Med Microbiol (2010) 0.95
Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease. J Clin Microbiol (2008) 0.88
Comparison of the suitability of three common bacterial media for susceptibility testing of trimethoprim-sulfamethoxazole. J Clin Microbiol (1984) 0.78
Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med (2007) 7.82
Extrapulmonary tuberculosis: an overview. Am Fam Physician (2005) 4.83
Clinical practice. Infection associated with prosthetic joints. N Engl J Med (2009) 4.26
Coccidioidomycosis. Clin Infect Dis (2005) 3.88
Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med (2004) 3.75
The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant (2013) 2.71
Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. J Clin Microbiol (2009) 2.69
Comparison of direct colony method versus extraction method for identification of gram-positive cocci by use of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2011) 2.67
From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev (2008) 2.47
Comparison of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometer to BD Phoenix automated microbiology system for identification of gram-negative bacilli. J Clin Microbiol (2011) 2.42
Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis (2008) 2.12
Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli. J Clin Microbiol (2013) 2.09
A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis (2013) 2.08
Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA (2003) 2.07
Prosthetic joint infection. Clin Microbiol Rev (2014) 1.97
Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination. J Clin Microbiol (2006) 1.93
Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N Engl J Med (2002) 1.92
Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis (2003) 1.89
Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis (2003) 1.86
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother (2007) 1.85
Emergence of a new pathogenic Ehrlichia species, Wisconsin and Minnesota, 2009. N Engl J Med (2011) 1.84
Identification of non-diphtheriae corynebacterium by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2011) 1.82
Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop Relat Res (2003) 1.82
Multiplex LightCycler PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens. J Clin Microbiol (2002) 1.72
Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture. J Clin Microbiol (2009) 1.69
Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis (2009) 1.62
Prosthetic joint infection diagnosis using broad-range PCR of biofilms dislodged from knee and hip arthroplasty surfaces using sonication. J Clin Microbiol (2012) 1.62
Three-hour molecular detection of Campylobacter, Salmonella, Yersinia, and Shigella species in feces with accuracy as high as that of culture. J Clin Microbiol (2010) 1.58
Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) (2002) 1.53
Influenza virus infection in adult solid organ transplant recipients. Am J Transplant (2002) 1.52
Rapid molecular microbiologic diagnosis of prosthetic joint infection. J Clin Microbiol (2013) 1.52
Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc (2006) 1.48
Performance of flow cytometry to screen urine for bacteria and white blood cells prior to urine culture. Clin Biochem (2013) 1.47
Percutaneous intervention for unprotected left main disease prior to explantation of a left ventricular assist device. Catheter Cardiovasc Interv (2003) 1.45
Long-term follow-up of a facilitated peer mentoring program. Med Teach (2013) 1.45
Formic acid-based direct, on-plate testing of yeast and Corynebacterium species by Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2012) 1.44
Intravenously administered pharmaceuticals impact biofilm formation and detachment of Staphylococcus lugdunensis and other staphylococci. Diagn Microbiol Infect Dis (2007) 1.43
Streptococcus salivarius bacteremia and spontaneous bacterial peritonitis in liver transplantation candidates. Liver Transpl (2007) 1.43
Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis. J Antimicrob Chemother (2005) 1.41
Meningococcal meningitis with brainstem infarction. Arch Neurol (2007) 1.39
Coccidioidal pneumonia, Phoenix, Arizona, USA, 2000-2004. Emerg Infect Dis (2009) 1.39
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob Agents Chemother (2006) 1.37
Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol (2008) 1.34
Facilitated peer mentorship: a pilot program for academic advancement of female medical faculty. J Womens Health (Larchmt) (2008) 1.33
Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J Infect Dis (2006) 1.30
Comparison of three preparatory methods for detection of bacteremia by MALDI-TOF mass spectrometry. Diagn Microbiol Infect Dis (2012) 1.29
Importance of using Bruker's security-relevant library for Biotyper identification of Burkholderia pseudomallei, Brucella species, and Francisella tularensis. J Clin Microbiol (2013) 1.28
Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations. Ann Surg (2013) 1.27
Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients. J Clin Microbiol (2012) 1.25
A biofilm approach to detect bacteria on removed spinal implants. Spine (Phila Pa 1976) (2010) 1.22
Possible overestimation of penicillin resistant Streptococcus pneumoniae colonization rates due to misidentification of oropharyngeal streptococci. Diagn Microbiol Infect Dis (2002) 1.22
An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction. J Clin Gastroenterol (2012) 1.21
Cryptococcosis in organ transplant recipients: an overview. Am J Transplant (2002) 1.21
Coccidioidomycosis. Mayo Clin Proc (2008) 1.20
C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infection. PLoS One (2010) 1.20
Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis (2002) 1.20
Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol (2012) 1.20
The electricidal effect: reduction of Staphylococcus and pseudomonas biofilms by prolonged exposure to low-intensity electrical current. Antimicrob Agents Chemother (2008) 1.17
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother (2008) 1.17
Laboratory and clinical characteristics of Staphylococcus lugdunensis prosthetic joint infections. J Clin Microbiol (2010) 1.17
Academic advancement of women in medicine: do socialized gender differences have a role in mentoring? Mayo Clin Proc (2008) 1.17
Isolation of Robinsoniella peoriensis from four human specimens. J Clin Microbiol (2010) 1.16
Rapid and simultaneous detection of genes encoding Klebsiella pneumoniae carbapenemase (blaKPC) and New Delhi metallo-β-lactamase (blaNDM) in Gram-negative bacilli. J Clin Microbiol (2013) 1.16
Reevaluation of Streptococcus bovis endocarditis cases from 1975 to 1985 by 16S ribosomal DNA sequence analysis. J Clin Microbiol (2002) 1.15
Corynebacterium prosthetic joint infection. J Clin Microbiol (2012) 1.15
High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis (2009) 1.15
Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 Assays for quantification of hepatitis C virus RNA in serum. J Clin Microbiol (2002) 1.15
Pilot study of association of bacteria on breast implants with capsular contracture. J Clin Microbiol (2009) 1.14
Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant (2004) 1.14
The electricidal effect is active in an experimental model of Staphylococcus epidermidis chronic foreign body osteomyelitis. Antimicrob Agents Chemother (2009) 1.14
A real-time combined polymerase chain reaction assay for the rapid detection and differentiation of Anaplasma phagocytophilum, Ehrlichia chaffeensis, and Ehrlichia ewingii. Diagn Microbiol Infect Dis (2005) 1.14
Comparative study of antimicrobial release kinetics from polymethylmethacrylate. Clin Orthop Relat Res (2006) 1.14
Evaluation of the MagNA pure LC instrument for extraction of hepatitis C virus RNA for the COBAS AMPLICOR Hepatitis C Virus Test, version 2.0. J Clin Microbiol (2003) 1.13
icaA is not a useful diagnostic marker for prosthetic joint infection. J Clin Microbiol (2004) 1.13
Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis (2002) 1.11
Intranasal exposure to staphylococcal enterotoxin B elicits an acute systemic inflammatory response. Shock (2006) 1.10
Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis (2013) 1.10
Parallel application of extracorporeal membrane oxygenation and the CardioWest total artificial heart as a bridge to transplant. Ann Thorac Surg (2009) 1.09
Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol (2004) 1.09
Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis (2006) 1.09
In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagn Microbiol Infect Dis (2006) 1.09
Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. Am J Infect Control (2013) 1.09
In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria. Diagn Microbiol Infect Dis (2004) 1.08
Opportunistic infections in patients with pulmonary alveolar proteinosis. J Infect (2012) 1.08
Pathogenesis and management of polyomavirus infection in transplant recipients. Clin Infect Dis (2002) 1.07
Gender distribution of U.S. medical school faculty by academic track type. Acad Med (2014) 1.07
Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis. Antimicrob Agents Chemother (2010) 1.07
Delayed-onset primary cytomegalovirus disease after liver transplantation. Liver Transpl (2007) 1.07
Bacterial, mycobacterial, and protozoal infections after liver transplantation--part I. Liver Transpl (2005) 1.06
Nocardia infection in lung transplant recipients. J Heart Lung Transplant (2002) 1.05
Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002. Antimicrob Agents Chemother (2004) 1.05
Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect Immun (2006) 1.05
Daptomycin in experimental murine pneumococcal meningitis. BMC Infect Dis (2009) 1.05
Diagnosis of prosthetic joint infection by use of PCR-electrospray ionization mass spectrometry. J Clin Microbiol (2013) 1.05
Antibacterial resistance leadership group: open for business. Clin Infect Dis (2014) 1.04